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Abstract
Background: Documented rates of dementia and cognitive impairment not dementia (CIND) in older Aboriginal
and Torres Strait Islander Peoples is 3–5 times higher than the rest of the population, and current evidence
suggests this condition is under-diagnosed and under-managed in a clinical primary care setting. This study aims to
implement and evaluate a culturally responsive best practice model of care to optimise the detection and
management of people with cognitive impairment and/or dementia, and to improve the quality of life of carers
and older Aboriginal and Torres Islander Peoples with cognitive impairment.
Methods/design: The prospective study will use a stepped-wedge cluster randomised controlled trial design
working with 12 Aboriginal Community Controlled Health Services (ACCHSs) across four states of Australia. Utilising
a co-design approach, health system adaptations will be implemented including (i) development of a best practice
guide for cognitive impairment and dementia in Aboriginal and Torres Strait Islander communities (ii) education
programs for health professionals supported by local champions and (iii) development of decision support systems
for local medical software. In addition, the study will utilise a knowledge translation framework, the Integrated
Promoting Action on Research Implementation in Health Services (iPARIHS) Framework, to promote long-term
sustainable practice change. Process evaluation will also be undertaken to measure the quality, fidelity and
contextual influences on the outcomes of the implementation.
The primary outcome measures will be rates of documentation of dementia and CIND, and evidence of improved
management of dementia and CIND among older Indigenous peoples attending Aboriginal and Torres Strait
Islander primary care services through health system changes. The secondary outcomes will be improvements to
the quality of life of older Indigenous peoples with dementia and CIND, as well as that of their carers and families.
Discussion: The Let’s CHAT Dementia project will co-design, implement and evaluate a culturally responsive best
practice model of care embedded within current Indigenous primary health care. The best practice model of care
has the potential to optimise the timely detection (especially in the early stages) and improve the ongoing
management of people with dementia or cognitive impairment.
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Background
Introduction
The Australian population of Aboriginal and Torres
Strait Islander peoples is growing, and the number of
people aged over 65 years is projected to nearly double
by 2026 [1]. Older Aboriginal and Torres Strait Islander
Australians play a crucial role in the health of their com-
munities, including as stewards of cultural rights and re-
sponsibilities for maintaining connections to Country,
caring for extended family members, and providing lead-
ership and support within their families and within com-
munities [2]. Although there are many examples of
Aboriginal and Torres Strait Islander Elders ‘ageing well’
[3], research has documented a high prevalence and inci-
dence of dementia and cognitive impairment not de-
mentia (CIND) in Aboriginal and Torres Strait Islander
Australians living in urban, rural and remote regions of
Australia [4–6]. Rates of dementia and CIND are up to 5
times those observed in the non-Indigenous population,
with onset at younger ages, and are influenced by poten-
tially modifiable risk factors such as head injury, cardio-
vascular disease and stroke. This is in contrast with
other research internationally, that demonstrates a de-
crease in dementia rates in some developed nations in
the last three decades [7, 8].
There is increasing evidence that prevention and man-
agement of vascular and other risk factors could delay
progression of dementia [9], and this may be of particular
relevance in Aboriginal and Torres Strait Islander com-
munities where there are high rates of co-morbid condi-
tions [10, 11] and onset at earlier ages, including past head
injury – a key risk factor associated with decline from nor-
mal cognition to impairment [4], and other associations
including age, stroke, non-aspirin analgesics, lower BMI,
and higher systolic blood pressure (BP) [4]. In addition
childhood trauma was found to be a contributor to cogni-
tive decline in urban regions [6, 12].
Primary health care teams play an essential role in the
detection and management of dementia in the commu-
nity, yet studies demonstrate that several factors affect
poor detection of dementia in primary care. These in-
clude lack of confidence to diagnose dementia, thera-
peutic nihilism and lack of access to specialist services
[13, 14]. In our study in the Kimberley, only 38% of
those with dementia and 3% with CIND had been diag-
nosed by general practitioners (GPs) or had their diag-
noses documented despite the study team informing the
GPs of these diagnoses (personal communication by
DL). This may reflect generally poor use of screening for
early detection and management of chronic disease [15],
with only 33% subsidised primary care screening com-
pleted for Aboriginal and Torres Strait Islander clients
[15, 16]. Other factors affecting timely diagnosis of de-
mentia for Aboriginal and Torres Strait Islander peoples
include stigma, poor health literacy, perceived lack of
culturally specific services, cultural understandings of
dementia, fear of having to leave Country, financial costs
and many competing priorities within family and com-
munities [2, 3, 17] – factors affecting the timely diagno-
sis of all chronic conditions.
Evidence shows that GP education may increase the
detection of suspected cases of dementia [18, 19] with
resulting improved quality of life of older people [13],
but effective translation also requires changes to routine
systems. Previous successful primary care interventions
to improve detection of dementia and CIND have in-
cluded a combination of strategies: decision support sys-
tems, availability of guidelines, one-to-one and group
education, and collaborative models of care including
nurse-led interventions [18, 20]. Efficacy of primary care
interventions for Aboriginal and Torres Strait Islander
peoples can be very high, as demonstrated by studies
such as the Aboriginal and Torres Strait Islander Health
Worker led intervention for diabetes management [21]
and a smoking intervention study in the Kimberley [22].
These and other studies emphasised the importance of
cultural safety, utilising Aboriginal and Torres Strait Is-
lander researchers and health workers, and a need for
local health services to assume ownership of the project
[20, 22]. Effective programs are also often supported by
a framework of Continuous Quality Improvement (CQI)
within Aboriginal and Torres Strait Islander primary
care settings [23–25].
To date no studies have been undertaken locally or
internationally to address the needs of Aboriginal and
Torres Strait Islander people with dementia and CIND
through primary care, despite the alarmingly high rates
of these conditions. The Let’s CHAT (Community
Health Approaches To) Dementia program addresses
the need to improve detection and management of de-
mentia and CIND in primary care by using a holistic
‘real world approach’, based on adapting current systems
and working collaboratively within ACCHSs and Com-
munities to enable immediate translational outcomes.
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The program will co-design, implement and evaluate a
culturally responsive best practice model of care embed-
ded within current Aboriginal and Torres Strait Islander
primary health care and ACCHS systems and services.
This will optimise the timely detection (especially in the
early stages) and ongoing management of people with
dementia or its precursor CIND.
Aims, objectives and outcomes of the study
The primary aim is to:
(i) Improve detection and management of dementia
and CIND among older Aboriginal and Torres Strait Is-
lander peoples attending primary care services through
health system changes that include the following
features:
(a) Collaboratively developed education programs
delivered for capability building of health
practitioners including Aboriginal and Torres Strait
Islander Health Workers, nurses and GPs. This
program will be supported by local champions.
(b) Development of a culturally appropriate Aboriginal
and Torres Strait Islander best practice guide (BPG)
for dementia and CIND, and;
(c) Decision support systems including software
modifications and adaptations of the current
Aboriginal Health Check (Medical Benefit Scheme
(MBS) 715) templates;
The secondary aims include improvement in the qual-
ity of life of carers and older people with dementia and
CIND.
Hypotheses
Primary hypothesis: Implementation of the Let’s CHAT
Dementia model of care and health system changes will
result in an increase in documentation of cognitive as-
sessment and management for dementia and CIND in
the clinic population aged 50 and over.
Secondary hypothesis: Compared with usual care, im-
plementation of the Let’s CHAT Dementia model of
care will: a) improve carers’ quality of life; and b) im-
prove health outcomes and quality of life of those with




This research project has adopted a stepped wedge cluster
randomised controlled trial design with 12 clusters
(ACCHSs) across four states of Australia. This method
was chosen for pragmatic and ethical reasons - each clus-
ter will experience the intervention over the course of the
study, contamination of the groups prior to intervention is
minimised due to geographic separation, and the design
minimises the difficulties of implementing a program sim-
ultaneously over large distances [26, 27].
In the context of Indigenous research, a community
participatory approach is essential to ensure the commu-
nity, service providers and stakeholders are involved at
all stages enabling successful translation into sustainable
outcomes [28]. The CQI “plan, study, do, act” cycle will
be utilised in combination with the i-PARIHS framework
with the purpose of being a practical and familiar way to
engage staff in practice change [29, 30]. The clinical and
support staff within each ACCHS will be invited by the
research staff to co-develop and participate in the imple-
mentation phase of the project – consisting of staff edu-
cation and resource development. Additionally, staff
from each ACCHS and local Community members will
be recruited to act as project Ageing Well Champions
(AWC) – co-researchers and leaders for change [24].
The primary role of AWCs will be to assist with imple-
menting the Let’s CHAT Dementia model of care. They
will be selected by ACCHS staff based on prior experi-
ence working with older Aboriginal and Torres Strait Is-
lander Australian peoples. A protocol will be developed
to outline the role of the champions.
A formal framework will be utilised to evaluate the na-
ture and quality of the implementation, given the com-
plexity of a multi-domain program and to determine
barriers and enablers to care in a real-world health ser-
vice intervention. In this project the iPARIHS framework
has been selected to inform the knowledge translation
aspects of the study [31]. This framework has been uti-
lised for similar complex interventions in primary care
and Aboriginal and Torres Strait Islander health care
with successful outcomes [30]. iPARIHS adopts the fol-
lowing formula: SI = Facn(I + R + C), where examination
and understanding of the Innovation (what is being im-
plemented and the evidence base supporting it), the Re-
cipients (who is exposed to the implementation both
individually and collectively) and the Context (inner and
outer) are crucial in determining the Successful Imple-
mentation of an intervention. The approach positions
the notion of Facilitation as the underlying element for
the enablement of successful implementation. This
framework will marry well with the co-design approach
being taken in this study; facilitation will be a key area of
focus to promote ongoing engagement from staff in co-
developing and taking ownership of the iteratively de-
signed model of care [30].
Setting
The study will be undertaken in North Queensland,
New South Wales, Victoria and Western Australia with
recruitment of three ACCHS in each state. Each health
service (cluster) will be randomised to determine the
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sequence of commencement of education and resource
provision (the implementation phase) and the ACCHSs
will enter the implementation phase of the study at six-
monthly intervals. Randomisation will be carried out by
a statistician external to the project team. One ACCHS
per state will begin the implementation phase at a time.
Allocation concealment will be ensured until the second
group of ACCHSs enters the intervention phase, at
which time all ACCHSs will be aware of their allocation
sequence. Blinding of trial participants (ACCHSs) and
data collectors will not be possible, since both groups
will be aware of and possibly engaged in the implemen-
tation activities taking place once a health service enters
the intervention phase. However, the research team
plans to recruit external outcome assessors to check data
samples. Table 1 (below) outlines the expected timeline
for each phase of the project.
Participants/recruitment
Organisations
Twelve ACCHSs in total will participate in the study,
three from each state involved. The recruitment of the
health care services is ensured as there are existing good
relationships with the practices, built during previous re-
search and collaborative projects. The 12 ACCHSs will
be initially engaged through conversations between se-
nior management staff and project investigators, with fa-
cilitation by peak bodies in some states.
Individuals
Patients identified through the medical record audit as
having documentation of suspected or confirmed de-
mentia or cognitive impairment and their carers will be
approached to participate in a comprehensive geriatric
assessment (CGA). The individual assessments will serve
the dual purpose of enabling the measurement of indi-
vidual outcomes across the course of the study and feed-
ing back care recommendations for patient management
from project geriatricians to ACCHSs and assisting with
health economic evaluation. For each person suspected/
identified as having cognitive impairment or dementia
two case controls matched for age and gender will also
participate in the CGA wing of the study. A known staff
member or clinician from the ACCHS will make con-
tact, inform the potential participants about the study
and introduce a research staff member. The research
staff member will then speak with the person/family to
provide further information on the study and invite the
person to participate.
Inclusion criteria
The organisations [1] and individual participants [2] se-
lected for the study will meet the following criteria:
1) ACCHSs that:
(i) Utilise a health care software system with
comprehensive electronic health records, such
as MMEx or Communicare [32, 33];
(ii) Utilise Medical Benefit Scheme (MBS) item 715
[34], which is a population-based health check
specifically designed for health promotion, dis-
ease prevention and early diagnosis in Aborigi-
nal and Torres Strait Islander populations;
(iii)Have GPs and Aboriginal and Torres Strait
Islander Health Workers, and/or practice nurses
who assist in delivery of health checks;
(iv) Participate in CQI [35]
(v) Can provide at least 55 current Aboriginal and
Torres Strait Islander patients who meet the
inclusion criteria.
Table 1. Project timeline
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2) Aboriginal and Torres Strait Islander Peoples aged
50 years and over who are active clients (at least
three visits in the last 2 years) of the health service.
Despite the MBS 715 being available for all ages
(with a category specific for 55 years and over), a
50-plus age group was chosen due to high rates of
CIND and dementia documented in this group [36]
and aligns with the age criteria for access to the
Australian Government’s aged care services plat-
form, My Aged Care [37].
Exclusion criteria
Clients will be excluded from audits in the following
cases. If they:
(i) Are severely unwell with high likelihood of death
within 6 months;
(ii) Have not resided in the area for the last 12 months;
(iii)Currently reside in residential care and/or;
(iv)Are not active patients of the service as defined by
the Royal Australian College of General Practitioners’
definition: having attended no less than three visits to
the service in the last 2 years [36].
Intervention
The implementation strategies for the intervention in
each cluster will be determined in collaboration with the
AWCs and local service leaders and will include the fol-
lowing elements:
(i) Education sessions, designed in collaboration with
ACCHS staff including Aboriginal and Torres Strait
Islander Health Workers, nurses and GPs, and
provided to the ACCHS staff through a method
that supports the needs of the health service. For
example, workshops, webinars, online educational
modules etc.; depending what the ACCHSs
determine is the most effective form of training for
their organisation.
(ii) Gaps and areas for practice development or
learning will be identified with each health service
team and organisation, based on results of the
medical record audits developed and undertaken
specifically for this project, together with feedback
from each agency. The research team will engage
with existing CQI processes in the health service to
reinforce practice change behaviours.
(iii)An evidence-based best-practice guide to cognitive
impairment and dementia care for older Aboriginal
and Torres Strait Islander peoples in primary care
will be developed and refined through extensive
stakeholder consultation, including a modified Del-
phi process [38], workshops with the project’s
Translation Working Group, and advice from the
project’s Aboriginal and Torres Strait Islander Ref-
erence Group.
(iv)Adaptation and modification of the standard
software used by primary care agencies to record
and manage client care. The inclusion of prompts,
decision support systems and adaptations to
templates such as chronic disease care plans and
Aboriginal Health Checks, and evidence-based guid-
ance regarding dementia assessment and care will
provide practical support for staff on a daily basis.
(v) Development of tailored care pathways for
individual ACCHSs.
Outcomes
The primary outcome is new documentation of dementia
or CIND within healthcare records. This includes: (i) evi-
dence of cognitive screening, and/or (ii) documentation of
inquiry into cognitive health (e.g. asking questions regard-
ing memory; obtaining informant report regarding cogni-
tion; (iii) laboratory or imaging investigations specifically
requested for assessment of dementia. The data informing
the primary outcome measure will be collected during
regular audit cycles (detailed below), both prior to and
during the project implementation phase.
Secondary outcomes are focused on improved health
and well-being of older Aboriginal and Torres Strait Is-
lander peoples with dementia, their carers and families.
This will be measured through two validated quality of
life tools in the CGA (refer below).
Dissemination and translation
Formal feedback of outcomes to health services
personnel will occur every 6 months. Regular community
updates will be provided through various culturally ap-
propriate media, including newsletters and posters. Two
workshops will be held (at baseline and on completion
of the project) in each region for consumers, carers,
health professionals, aged care workers and all other
relevant stakeholders to provide and discuss information,
present findings, and to set research priorities for the fu-
ture. Ongoing translation strategies will be developed in
collaboration with AWC and relevant stakeholders.
Methods: data collection, management and analysis
Data collection and management
Medical record audit A specific audit tool has been de-
veloped to collect data from eligible ACCHS clients 50
years and over (see Table 2 for data collection timetable).
The audit tool documents clients’ dementia risk profile,
any assessments or investigations relating to cognition,
new diagnoses of dementia and CIND as well as describing
the care pathways of any cognitively impaired clients, in-
cluding referrals, hospitalisations and mortality. Data will
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be collected by trained research assistants using REDCap;
an online, secure, password protected, web-based data col-
lection support tool. Data will be de-identified with a
unique identifier code allocated to each participant to en-
able linking between successive audits, with data re-
identifiable only in the clinical setting. Audits will be com-
pleted either by trained research assistants or ACCHS
staff, depending on each service’s preferences.
Comprehensive geriatric assessment (CGA) - client
Patients identified with possible dementia or CIND by
audit and the gender and age matched case controls will
be invited to be participants in the CGA. Different mea-
sures will be utilised in the CGA to gather data to assess
individual outcomes throughout the life of the study. Cog-
nition, quality of life, chronic pain, continence, daily func-
tion, mental health, history of psychosocial stress,
nutrition, physical activity, sleep quality, frailty, visual and
hearing impairment, muscle mass, blood pressure, grip
strength and gait will be assessed (see summary table, Ap-
pendix 1, for standardised tools used). The CGA contains
a detailed cognitive assessment section which includes the
Kimberley Indigenous Cognitive Assessment, the Clock
Test, Colour Trail Making Test and the Symbol Digit Mo-
dalities Test [39–42]. A semi-structured interview will be
used to ascertain demographic factors, preferred language
and education. Structured responses will be sought from
the participants on the following: medical history, medica-
tions, past and present tobacco use (including chewing to-
bacco), past and present alcohol use, past and present
drug use and history of head trauma. The CGA survey in-
formation will be collected by trained research assistants
and will be entered and stored securely in REDCap. Paper
copies will be stored in locked file cabinets in areas access-
ible by project research team members only.
Comprehensive geriatric assessment - Carers/ family
Carers and/or family will also be invited to complete a
section of the CGA. They will be asked to assess the pa-
tient’s health. Frailty, cognition, daily function, mental
health, and nutrition will be assessed. In addition, a semi-
structured interview will be used to ascertain both past
and present smoking (including chewing tobacco), alco-
hol, and drug use by the patient from the carer and/or
family member’s perspective. Different measures will also
be utilised to assess the carer’s and/or family member’s
health, including a carer burden interview, a mental health
assessment and a quality of life test. Individual and carer/
family assessments will be completed by trained research
assistants. The CGAs will be reviewed by geriatrician who
will make care recommendations regarding clinical man-
agement and care which will be fed back to ACCHSs.
Data collection timetable
Table 2. Data collection timetable




Audit tool: demographic data &
dementia mapping
X X X
Documentation of dementia or CIND
(audit tool)
X X X




Carer: Outcomes X X
Health professionals: Process data X X X
a6 monthly collection of data will continue from baseline to 36 months
Harms
Solicited and spontaneously reported adverse events and
other unintended effects of the trial interventions or trail
conduct will be managed by the Project Management
team. This will be achieved through prior planning to
mitigate potential harmful outcomes, and the availability
of the Project Management team to address concerns and
issues as they arise. For example, some of the questions in
the CGA have the potential to cause distress to
participants, as some questions ask the participants about
possible negative life events they may have experienced.
To mitigate and manage potential harmful outcomes for
participants partaking in a CGA, researchers administering
the CGA will be trained to follow a protocol for
monitoring participant distress levels, as well as, reporting
guidelines to follow in such cases. For example, dependant
on the circumstances, it may be necessary for the
researcher to consult with the participants GP who can
then organise a referral to a psychologist, or perhaps, in a
different circumstance, it may be appropriate to provide
the participant with information about support services
available in the local area.
Consent
Organisational consent will be sought from the ACCHSs
for participation in the research project, including for the
audits carried out as part of a quality assurance process.
Individual informed consent will be sought from ACCHS
staff participating in the co-design and evaluation of the
best-practice model of care. Individual informed consent
will also be sought from the clients, carers and family
members participating in the CGA, this will be achieved
by providing study participants with a Plain Language
Statement that clearly outlines the study processes (refer
to Appendix 2 Plain Language Statement).
For individual consent processes, interpreters will be
used as required. Some of the people invited to take part
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in the project will have dementia or other forms of
cognitive impairment. If, as determined by a trained
clinician, a person does not have capacity to give consent
for participation in the detailed assessment and record
linkage, consent will be sought from the carer, next of kin
or a statutory health attorney/guardian.
Project evaluation
Process evaluation
A mixed methods approach will be used for the process
evaluation of the implementation [43]. Fidelity, dose and
reach of the intervention will be measured and evaluated
by a project-appointed sub-committee.
Qualitative data for the process evaluation will be
collected from all sites during the study. Data collection
will include:
 Interviews with ACCHS staff at multiple time points
during the implementation phase of the study to
capture experiences of the intervention. Interview
participants will be recruited via purposive sampling,
to provide a representative sample of different roles
within the health service (eg. GPs, nurses, AHWs,
administrative staff, allied health staff) levels of
exposure to (and possibly attitudes towards) the
implementation;
 Project research staff notes documenting
observations made during visits to ACCHSs and
other contact with ACCHS staff (including phone
calls and emails);
 Any feedback from AWCs regarding the
implementation.
The iPARIHS framework will be used to guide the
implementation. As such, all data collected for the
process evaluation will focus on the characteristics of
the implementation of the best-practice model of care
for cognitive impairment and dementia (the innovation),
who is affected by it (the recipients) and how they are af-
fected by it, the inner and outer contexts within which
the model of care is being implemented, as well as the
facilitation of the implementation.
Health economic analysis
An economic evaluation will be conducted as part of
this study. Best-practice methods will be utilised to
undertake a cost-utility analysis of the intervention with
quality of life as measured and valued by the EQ-5D as
the primary outcome measure [44]. Resource use associ-
ated with the development and implementation of the
Let’s CHAT model of care (including staff time spent
developing and administering the program, consum-
ables, software development and others) will be carefully
documented, measured and valued.
Quality Assurance & Data Monitoring
A Data Monitoring Committee (DMC) has been
established. The DMC is not independent from the study
organisers and is composed of the central management
team. The DMC will undertake check and data cleans
periodically for all study sites to ensure data collection
adheres to the study protocol. Spot checks will also be
undertaken on a semi-regular basis by a member of the
DMC to assess the reliability of the data collected from
the different ACCHSs involved in the study. Quality assur-
ance of data collected in this study will be validated
through electronic checks via the REDCap system (used
for data collection in this project). These data monitoring
processes will ensure that the quality and completeness of
the data will be maintained over the course of the project.
Analysis and sample size
Analysis
Statistical analysis will be conducted using generalised
linear mixed models (GLMM) where variation between
clusters will be modelled as a random intercept effect
and, nested within these, time will be treated as a
random coefficient effect. No single model can assess all
the possible time-related effects that may be of interest
and to this end up to four different model configurations
will be used as outlined in Twisk et al. [45].
Sample size
Previous work in the Kimberley (confirmed by work in
NSW) found that in Aboriginal and Torres Strait Islander
communities, based on community screening, the true
prevalence of dementia in people aged 45 years and over
was approximately 10%, and the prevalence for cognitive
impairment without dementia was also approximately 10%
[5, 45]. Hence, the true prevalence of dementia or cognitive
impairment in the relevant population is 20%. In the
Kimberley, only 38% of those with dementia and only 3%
of those with cognitive impairment had been diagnosed by
primary health care practitioners. Moreover, the fraction of
dementia cases identified by primary care in this work was
likely to be higher than in standard practice as many of
those with diagnosed dementia had been identified as part
of previous research, with primary care practitioners
subsequently notified. Therefore, we assume that no more
than 15% of individuals with cognitive impairment or
dementia are currently identified by primary health
practitioners. The initial prevalence based on detection in
primary care will be 15% of 20%, i.e. 3%. At a minimum,
the study intervention should enable practitioners to
identify at least half (50%) of the primary care patients with
dementia or cognitive impairment. This would increase the
prevalence based on detection in primary care to 50% of
20%, i.e. 10%. If an intraclass correlation of 0.01 and an
average cluster size of 50 individuals is assumed, then the
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design effect will be 1.49. If the study was an individually
randomised trial and we wished to detect an increase in the
identification of cognitive impairment and dementia from
3 to 10% then the sample size would need to be at least
388 people (α = 0.05, power = 0.8). Therefore, the sample
size required for this cluster randomised study will be 578
(388 × 1.49). Allowing for 10% drop-outs we plan to recruit
12 clusters of at least 55 people each, a total sample size of
at least 660 individuals. Secondary outcomes compare the
effect of earlier detection on scales of depression and stress
and this sample size also has adequate power for these
scales. We expect approximately 18 cases to be detected in
the control period and 60 in the intervention period. The
average cluster size will be 6.5 and assuming an ICC of
0.01, the design effect will be 1.055. Thus, our effective
number of control cases will be 17 (18/1.055) and interven-
tion cases 57 (60/1.055). Based on the variation found on
the longitudinal data of carer strain in the Kimberley, our
proposed study will provide over 80% power to find any
clinically important effects.
Discussion
The Let’s CHAT Dementia project aims to deliver a model
of care for cognitive impairment and dementia in Aboriginal
and Torres Strait Islander primary care settings. The co-
design nature of this study will be essential to maximise
learning and ensure a successful and sustainable result. Pre-
vious research has demonstrated the efficacy of participatory
research design frameworks in Aboriginal and Torres Strait
Islander health contexts. Such research projects have proven
successful because they embrace two-way learning and are
adapted to the cultural and historical community setting, in-
creasing chances of uptake [28]. This project will involve the
ACCHS research partners and their staff in decision-making
processes pertaining to the design and implementation of
the study, as well as appointing a project Aboriginal and
Torres Strait Islander Reference Group whose members will
be Aboriginal and Torres Strait Islander researchers, profes-
sionals in the health sector and community members with a
background/interest in advocating for Elders, ageing well
and cognitive health issues. Health care professionals are
ideally positioned to help inform the design of interventions
in their own work contexts. They have firsthand, experien-
tial knowledge of the environment and the people within it,
including specific cultural knowledge of the groups being
served. Co-design frameworks also provide an important
safeguard for communities involved in research, and are a
key attribute in providing cultural safety to vulnerable
groups [46]. Extensive, regular consultation with a range of
Aboriginal and Torres Strait Islander representatives on all
aspects of the project throughout the course of this research
will help to ensure that the project is conducted ethically,
appropriately and respectfully.
The prior translational work undertaken with older
Aboriginal and Torres Strait Islander Australians
appropriately positions this study toward reaching the
project’s main goals [2, 39, 47]. Such work includes
development and validation of culturally appropriate
screening tools, the development of health and community
care pathways, and the detailed documentation of unmet
needs of those with dementia and their carers, and, the
previous successful implementation of primary care
interventions in Aboriginal and Torres Strait Islander
settings [2, 39, 47]. In addition, substantial groundwork in
the form of developing networks and relationships with
communities, services and stakeholders across the four
states involved has already been laid.
A strength of this study is the adaptability of the
implementation design to meet the needs of each specific
health practice context (the individual ACCHSs). However,
this may equally impact the ability of the project to
maintain fidelity when dealing with the disparate groups
involved. While this approach could affect the
generalisability of conclusions drawn from the research, the
relatively large number of sites involved (n = 12) from four
states in Australia will provide the study with rich,
qualitative data both in terms of individual case studies for
each health service and aggregated service data concerning
the processes undertaken. This means that, considered
globally or in parts, the transferability of the research design
and model of care of the study to other Aboriginal and
Torres Strait Islander health contexts will be high.
Lastly, a potential barrier to this study will be the
implementation of the CQI process within each health
service, which is a central methodological pillar of this
study with the purpose of facilitating reflective thinking in
the ACCHS. Current international literature highlights that
the implementation of CQI is difficult, the effects are
variable and little evidence exists on the factors enhancing
or impeding successful implementation of CQI [48].
Conversely, there is a growing body of literature which
demonstrates the effectiveness and the importance of CQI
frameworks in improving service delivery and clinical
outcome measures for Aboriginal and Torres Strait
Islander people and, further, CQI programs are widely
accepted and implemented by ACCHSs in the Australian
context [23, 48, 49]. It is hoped, through the utilisation of
the CQI “plan, do, study, act” [29] cycle supplemented by
audit tools developed to support actioning plans that are
guided by best practice and developed alongside the i-
PARIHS framework, barriers to the implementation of CQI
will be overcome in this project [30].
Conclusion
During this project ACCHS staff will improve capacity to
diagnose, manage and support older Aboriginal and Torres
Strait Islander clients with cognitive health concerns, and
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their carers, families and communities. Staff will have the
opportunity to actively participate in research and share or
further develop their skills. In the participating ACCHSs,
best practice recommendations for cognitive impairment
and dementia care will be provided along with review and
quality improvement of services. These include support to
achieve required reporting and strengthening of service
development activities. This study will test ways in which
to build staff capacity and foster the translation of best
evidence into everyday best practice.
Considering the higher rates of dementia in the
Aboriginal and Torres Strait Islander Australian population
and the current evidence that dementia and CIND is
underdiagnosed and under-managed in a clinical primary
care setting, there is a need for research that addresses the
need for improved detection and management of dementia
and CIND among older Aboriginal and Torres Strait Is-
lander peoples attending ACCHS and a focus on the im-
provement of quality of life for older Aboriginal and Torres
Strait Islander peoples with dementia and cognitive impair-
ment, their carers, families and Communities.
Although there is no cure for dementia, there are many
modifiable risk factors that can be addressed across the
life-course. Further, secondary prevention measures can
be effective for those with cognitive impairment, and
greater support and more effective management are pos-
sible once people have a diagnosis. Timely diagnosis gives
the best opportunity to ensure that optimal care is pro-
vided and that each individual and their carer and family
are well supported. Thus, strengthening the capacity of
ACCHSs to detect and manage the dementia journey with
older clients is a priority for health care research.
Appendix 1
Comprehensive geriatric assessment; standardised tool
list
Comprehensive Geriatric
Assessment: List of Standardized
Tools included.
Description of Standardized Tools.
Charlson Comorbidity Index (CCI)
[50].
The CCI was developed to measure
the comorbidity in relation to life
expectancy [50]. For this project,
the language utilized in this tool
has been adapted to be more
culturally appropriate.
Current Alcohol Consumption –
Audit C Tool [51].
The AUDIT -C Tool is a three-
question abbreviated version of the
alcohol use disorders test (AUDIT).




The KICA is a validated cognitive
screening tool designed to assess
cognition in older Indigenous
Australians [39].
Colour Trail Making Test (CTMT) The CTMT was developed to assess
Appendix 1 (Continued)
Comprehensive Geriatric
Assessment: List of Standardized
Tools included.
Description of Standardized Tools.
[41]. sustained attention in adults, whilst
being free of both language and
cultural bias [41].
Digit Symbol Modalities Test
(DSMT) [42]
The DSMT is designed to detect
cognitive impairment by screening
for organic and cerebral
dysfunction [42].
EQ 5D [52]. EQ 5D is a comprehensive quality
of life instrument developed to
explain and value health [52].
Good Spirit Good Life Quality of
Life Tool (GSGL) [53] .
The GSGL Tool was designed to
identify the quality of life needs of
older Aboriginal Australians with
cognitive impairment and dementia
[53].
Rapid Assessment of Physical
Activity (RAPA) [54].
The RAPA was designed to assess
levels of physical activity among
adults 50 years and over [54].
Elderly Falls Screening Scale (EFST)
[55].
The EFST is a five -Item test used to





The ICIQ is a questionnaire which
was developed to assess urinary
incontinence and its effect on
quality of life [56]. For the purposes
of this project the ICIQ has been




The GSAQ is an assessment tool
developed to screen for sleep
disorders [57].
Kimberley Indigenous Cognitive
Assessment -Depression (KICA -
Dep) [58].
The KICA – Dep was developed as
a culturally sensitive and valid scale
to assess depressive symptoms in
older Indigenous Australians [58].
Exhaustion - CES–D Depression
Scale [59].
Two questions were taken from The
CES -D Scale and included in the
comprehensive geriatric assessment
to assess exhaustion. The CES – D
Scale is a self- report scale to
measure depressive symptoms [59].
Geriatric Anxiety Inventory - Short
Form (GAI-SF) [60].
The GAI -SF is a 5-item version of
the Geriatric Anxiety Inventory de-
veloped for measuring Generalized
Anxiety Disorder [60].
Negative Life Events Scale (NLES)
[61].
The NLES was developed to
measure chronic stress in
Indigenous Australian populations
[61].
Mini Nutritional Assessment (MNA)
[62].
MNA is validated assessment
instrument developed to assess
nutritional problems [62].
Fried Frailty Index (FFI) [63]. FFI is an index used to assess frailty
in older adults [63].
Kimberley Indigenous Cognitive
Assessment (KICA)- Carer [64].
The KICA Carer is an informant
information questionnaire designed
to supplement the Kimberley
Indigenous Cognitive Assessment
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Appendix 1 (Continued)
Comprehensive Geriatric
Assessment: List of Standardized
Tools included.
Description of Standardized Tools.
Tool [64].
Adapted Zarit − 6 item Carer
Burden Interview [65].
The Burden Interview (ZBI) is a self-
report measure to assess the level
of burden experienced by care-
givers [65]. For the purposes of this
project the interview has been
adapted from 29 item version to a




Project: Let’s CHAT (Community Health
Approaches to) Dementia.
A/Prof Dina LoGiudice, Dr. Jo-anne Hughson (Re-
sponsible Researcher)Tel: + 61,481,900,008 Email: Dina.
LoGiudice@mh.org.au, hughson@unimelb.edu.au
What is this research about?
This research project will work to improve health care
for people in the [insert name here] Community aged 50
and over. We will do this by checking health records every
6 months, and working with the staff at the health service
and with the community to look after older people better.
We hope this will improve health and well-being for indi-
viduals, their families, carers and the Community. We are
interested in thinking and memory problems that might
be linked to dementia. Being part of this study doesn’t ne-
cessarily mean you have dementia or memory issues.
What will I be asked to do?
One of our trained research assistants will ask you
questions about your memory and thinking, and do
some health checks. This will take about 1 h, and a half
and will happen every year, for 4 years. The research
assistant can meet you at the clinic or at your home. S/
he will also talk with your main carer or someone in
your family to ask how they are and how much help
they give you. This information will be kept confidential,
or shared with your doctor and clinic if you agree.
We also want to learn about how much health care costs
for people over 50 in Aboriginal Communities. This
includes when you go to the doctor, the hospital, have tests
or take medicines. Medicare, the Pharmaceutical Benefits
Scheme (PBS) and the State Health departments keep
records of this information for everyone. With your
consent, we can access your information. A consent form is
attached, which includes an example of the records we
would receive. The consent form is sent securely to the
Department of Human Services and this information is kept
private. We will also ask for access to records of hospital
admissions, emergency departments, and ambulance
services via the State Health departments. If you agree to
this, we will handle all information carefully to make sure it
is safe. We will then combine this information with the
information we collect talking to you and your carer.
What are the possible benefits?
We hope that by training and supporting the staff of
Health Services we can improve the care and health of
older Aboriginal and Torres Strait Islander peoples, their
families and community. To help cover your time or any
out of pocket costs, we can reimburse you $50 each time
you are interviewed.
What are the possible risks?
There is a low risk that people may be upset by some
questions asked in the interviews. You can stop the
interview at any time. If you feel upset by any questions, the
researcher will help you get support from the health service.
Do I have to take part and what happens to my
information?
Being part of the study is completely voluntary. You can
pull out at any time. If you wish to pull out, you can do so
by contacting [nominate an appropriate “arms length”
person/local contact for each jurisdiction/ACCHS and
give phone number]. If you decide to pull out, we will not
collect additional personal or health information from
you, but if you give us permission we will use the
information you have already provided.
We are very careful about protecting your privacy. We
use number codes instead of names to store most of your
information, so that only the people working directly with
you will know your name and contact details. Researchers
who look at your results later will only see the number
codes, not your name and nothing that identifies you
individually will ever be reported on.
Paper-based consent forms will be stored in a locked
cabinet in the project team’s office at the Royal Melbourne
Hospital. Computer files will be stored without identifying
information such as names or date of birth, on a password
protected research study computer which only the
research team can access. By law, we need to keep the
research data for 5 years after the study is finished. After
this period, it will be destroyed.
Who is funding this project?
This project is funded by the National Health and
Medical Research Council (NHMRC).
Where can I get further information?
If you would like more information about the project,
please contact the researchers; A/Prof Dina LoGiudice
or Dr. Jo-anne Hughson (Responsible Researcher).
Tel: + 61,481,900,008 Email: Dina.LoGiudice@mh.org.au;
hughson@unimelb.edu.au
Who can I contact if I have any concerns about the
project?
Your health service is working with the research team
on this project. This project has been approved by the
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Aboriginal Health and Medical Research Council of NSW
and the Western Australian Aboriginal Health Ethics
Committee (WAAHEC). If you have any concerns or
complaints about the conduct of this research project you
can talk to [local health service coordinator]. If you do not
wish to talks to the research team or the health service,
you can contact: The Chairperson, AH&MRC Ethics
Committee, Tel: (02) 9212 4777 or The WAAHEC Ethics
Officer, Email: ethics@ahcwa.org, Tel: (08) 9227 1631.
All complaints will be treated confidentially. In any
correspondence please provide the name of the research
team or the name or HREC reference number of the
research project.
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